Literature DB >> 30028000

Use of PD-1 (PDCD1) inhibitors for the treatment of Richter syndrome: experience at a single academic centre.

Kerry A Rogers1, Ying Huang1, Emily Dotson2, Jordan Lundberg2, Leslie A Andritsos1, Farrukh T Awan1, Jennifer A Woyach1, John C Byrd1.   

Abstract

Entities:  

Keywords:  PD-1 (PDCD1) inhibitors; Richter syndrome; chronic lymphocytic leukaemia; immune checkpoint inhibitors

Mesh：

Substances：

Year:  2018        PMID： 30028000     DOI： 10.1111/bjh.15508

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  5 in total

Review 1.  Richter's Transformation.

Authors:  Audrey M Sigmund; Adam S Kittai
Journal:  Curr Oncol Rep       Date:  2022-04-06       Impact factor: 5.945

Review 2.  Microenvironment Remodeling and Subsequent Clinical Implications in Diffuse Large B-Cell Histologic Variant of Richter Syndrome.

Authors:  Hélène Augé; Anne-Béatrice Notarantonio; Romain Morizot; Anne Quinquenel; Luc-Matthieu Fornecker; Sébastien Hergalant; Pierre Feugier; Julien Broséus
Journal:  Front Immunol       Date:  2020-12-14       Impact factor: 7.561

Review 3.  Immune Dysfunctions and Immune-Based Therapeutic Interventions in Chronic Lymphocytic Leukemia.

Authors:  Valentina Griggio; Francesca Perutelli; Chiara Salvetti; Elia Boccellato; Mario Boccadoro; Candida Vitale; Marta Coscia
Journal:  Front Immunol       Date:  2020-11-18       Impact factor: 7.561

Review 4.  Novel Approaches for the Treatment of Patients with Richter's Syndrome.

Authors:  Andrea Iannello; Silvia Deaglio; Tiziana Vaisitti
Journal:  Curr Treat Options Oncol       Date:  2022-03-16

5.  Circulating tumor DNA for comprehensive noninvasive monitoring of lymphoma treated with ibrutinib plus nivolumab.

Authors:  Alessio Bruscaggin; Lodovico Terzi di Bergamo; Valeria Spina; Brendan Hodkinson; Gabriela Forestieri; Ferdinando Bonfiglio; Adalgisa Condoluci; Wei Wu; Maria C Pirosa; Martin R Faderl; Ricardo Koch; Michael Schaffer; John D Alvarez; Nele Fourneau; Bernhard Gerber; Georg Stussi; Emanuele Zucca; Sriram Balasubramanian; Davide Rossi
Journal:  Blood Adv       Date:  2021-11-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.